Company profile: Conatus Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of human therapeutics focused on liver disease and cancer, offering Emricasan, an orally active pan-caspase protease inhibitor for liver disease, plus medications including Vibramycin (doxycycline) and Tetracycline antibiotics, Stendra generic for erectile dysfunction, and Aralen generic for malaria prevention and treatment.
Products and services
- Aralen Generic: A generic antimalarial medication used to prevent and treat malaria for prophylaxis and therapy
- Emricasan: An orally active pan-caspase protease inhibitor engineered to treat liver disease with oral bioactivity and pan-caspase inhibition
- Stendra Generic: A generic medication used to treat erectile dysfunction by increasing blood flow to the penis to facilitate treatment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Conatus Pharmaceuticals
WellVia
HQ: United States
Website
- Description: Provider of telehealth services via proprietary cloud-based software and the Recuro Care App, enabling users and employees to connect within minutes to U.S. board-certified physicians licensed in their state, manage medical records, and communicate with healthcare providers, supported by an in-house call center staffed 24/7/365 by medical professionals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WellVia company profile →
Cerebral
HQ: United States
Website
- Description: Provider of mental health telemedicine services focused on democratizing access to high-quality care. Offers accessible and affordable support to help people feel better, faster, delivered by care experts who follow the latest science and evidence-based guidelines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerebral company profile →
Nutriumph
HQ: United States
Website
- Description: Provider of nutraceutical supplements for preventative healthcare, manufacturing brain vitamins for memory and concentration, weight loss aids, and multi collagen peptides powder with all five types of hydrolyzed collagen, plus other antioxidant-supporting products. Offers HERBERALL, a natural nootropic for focus, mood, clarity, memory, and energy, intended as an alternative to ADD/ADHD prescription drugs, and meal plan guides.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutriumph company profile →
Headway
HQ: United States
Website
- Description: Provider of a mental healthcare system operating a virtual network of therapists that accept insurance, offering online booking for video or in-person sessions. Supports providers in accepting insurance and scaling their practices, and helps individuals access affordable care and save on mental health sessions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Headway company profile →
TheraWe
HQ: United States
Website
- Description: Provider of pediatric therapy and parent engagement services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TheraWe company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Conatus Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Conatus Pharmaceuticals
2.2 - Growth funds investing in similar companies to Conatus Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Conatus Pharmaceuticals
4.2 - Public trading comparable groups for Conatus Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →